MiR-143 can suppress cell proliferation and migration and promote apoptosis in BC by inhibiting PI3K/Akt and MAPK signaling and targeting AKT47, KRAS48, ERK549, and PAI-145. This evidence concerns the gene AKT1 and breast cancer.